Information for Schools and Children's Education/Care

Schools and Children's Education/Care Survey June 2023

ASCIA invites all people studying and/or working in schools and children’s education/care (CEC) services to participate in this survey. Share your experience about anaphylaxis training to help improve training for staff and students. Complete this survey at https://ascia.qualtrics.com/jfe/form/SV_e5TVCMU4uUX7qwC for your chance to win one of TEN $100 gift vouchers.

Survey closes 30 June 2023.

SCEC Survey 2023

ASCIA is working on a National Allergy Council project to find out how anaphylaxis and allergy training is being provided in undergraduate courses for staff who work in schools and CEC services. Findings from this project will be used to make recommendations about how anaphylaxis and allergy training should be included in courses.

ASCIA Anaphylaxis e-training for Schools and Children's Education/Care

www.allergy.org.au/patients/anaphylaxis-e-training-schools-and-childcare 

Allergy Aware

https://www.allergyaware.org.au/

The Allergy Aware website is an anaphylaxis and allergy resource hub for schools and children's education/care (CEC) services which includes best practice guidelines and risk minimisation strategies for prevention of severe allergic reactions (anaphylaxis) in schools and CEC services:

https://www.allergyaware.org.au/schools/best-practice-guidelines-schools

https://www.allergyaware.org.au/schools/anaphylaxis-risk-minimisation-strategies

https://www.allergyaware.org.au/childrens-education-and-care/best-practice-guidelines-cec 

https://www.allergyaware.org.au/childrens-education-and-care/anaphylaxis-risk-minimisation-strategies

Adrenaline (Epinephrine) Injector Training Devices

ASCIA anaphylaxis e-training courses should always be completed in conjunction with practice using adrenaline (epinephrine) injector training devices (EpiPen® and Anapen®), which do not have a needle and do not contain adrenaline.  To order trainer devices contact:

  • EpiPen - Viatris AU - phone 1800 931 625 or Viatris NZ - phone 0800 168 169
  • Anapen - Allergy Concepts - email This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Pharmacies
  • Patient support organisations - Allergy & Anaphylaxis Australia www.allergyfacts.org.au 
    and Allergy New Zealand www.allergy.org.nz

The supervisor or other adult witness (18 years or older) who signs the certificate to confirm practice with the adrenaline injector trainer devices does not require any special qualifications (except in Victorian state schools - see https://www.allergy.org.au/patients/anaphylaxis-e-training-schools-and-childcare#ad3).  They can refer to instructions on ASCIA Action Plans or videos on the ASCIA website www.allergy.org.au/anaphylaxis 

ASCIA Anaphylaxis Resources

ASCIA anaphylaxis resources (including action plans, e-training courses and guidelines) are used throughout Australasian schools and children's education/care services. These resources are available at www.allergy.org.au/anaphylaxis  

National Allergy Strategy 250K Youth Project Resources

https://nationalallergystrategy.org.au/resources/250k-youth-project

pdfAllergy Aware presentation primary school 20211.20 MB

Allergy Aware presentation primary school 2021

pdfAllergy Aware presentation secondary school 20211.15 MB

Allergy Aware presentation secondary school 2021

Supply Update - Adrenaline (Epinephrine) Injectors 

For updated information go to www.allergy.org.au/members/adrenaline-autoinjector-availability 

Patient/Carer Support Organisations

www.allergy.org.au/patients/patient-support-information 

 

Webpage updated May 2023

Mod ASCIA Member
Donate to AIFA
go to NAC website
About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Information Partner

Official Information Partner of Healthdirect Australia